- Home
- PMEC vs IPA Comparison
PMEC vs IPA Comparison
Compare PMEC & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- IPA
- Stock Information
- Founded
- PMEC 1984
- IPA 1983
- Country
- PMEC Singapore
- IPA United States
- Employees
- PMEC N/A
- IPA N/A
- Industry
- PMEC
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- IPA Health Care
- Exchange
- PMEC Nasdaq
- IPA Nasdaq
- Market Cap
- PMEC 46.1M
- IPA 46.0M
- IPO Year
- PMEC 2023
- IPA 2017
- Fundamental
- Price
- PMEC N/A
- IPA $1.28
- Analyst Decision
- PMEC
- IPA Strong Buy
- Analyst Count
- PMEC 0
- IPA 2
- Target Price
- PMEC N/A
- IPA $4.00
- AVG Volume (30 Days)
- PMEC 52.6K
- IPA 5.1M
- Earning Date
- PMEC 01-01-0001
- IPA 07-28-2025
- Dividend Yield
- PMEC N/A
- IPA N/A
- EPS Growth
- PMEC N/A
- IPA N/A
- EPS
- PMEC N/A
- IPA N/A
- Revenue
- PMEC $74,310,000.00
- IPA $16,581,105.00
- Revenue This Year
- PMEC N/A
- IPA $4.67
- Revenue Next Year
- PMEC N/A
- IPA $14.15
- P/E Ratio
- PMEC N/A
- IPA N/A
- Revenue Growth
- PMEC 3.94
- IPA 1.34
- 52 Week Low
- PMEC $0.49
- IPA $0.27
- 52 Week High
- PMEC $1.49
- IPA $1.31
- Technical
- Relative Strength Index (RSI)
- PMEC 68.28
- IPA 79.18
- Support Level
- PMEC $1.26
- IPA $1.00
- Resistance Level
- PMEC $1.46
- IPA $1.15
- Average True Range (ATR)
- PMEC 0.12
- IPA 0.13
- MACD
- PMEC 0.03
- IPA 0.02
- Stochastic Oscillator
- PMEC 97.96
- IPA 100.00
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.